Clinical UpdatesDrug News

The FDA has loosened restrictions on the diabetes drug rosiglitazone (Avandia) - under fire since 2007 because of potential cardiovascular… »   

In the field of drug design, the protein K-Ras is legendary. It’s been on everyone’s “target” list for more than… »   

Horizon Pharma Inc said it would buy the right to market AstraZeneca Plc’s arthritis drug Vimovo in the United… »   

About 120 million people around the world with Type 2 diabetes - and two million in Canada - take the… »   

GlaxoSmithKline’s drug sales in China slumped 61 percent in the third quarter, hit by a bribery scandal that damaged its… »   

Time is running out for a dying Denver father who is pleading with drug companies for access to a… »   

A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

“We are the… »   

Repurchasing L’Oreal’s 9 percent stake in Sanofi might make sense for the French drugmaker if the $12 billion holding is… »   

A federal U.S. judge issued a temporary injunction against Hanmi Pharmaceutical Co Ltd on Friday, preventing the South Korean drugmaker… »   

Japanese drugmaker Otsuka Holdings Co said on Thursday that it had agreed to buy Astex Pharmaceuticals Inc for close to… »   

Generic drugmaker Akorn Inc will buy rival Hi-Tech Pharmacal Co Inc for $640 million to expand its eye drug portfolio… »   

Bayer’s cancer drug Nexavar was given priority review status by U.S. healthcare regulators for the oral drug’s use against a… »   

The Michigan state Senate on Tuesday voted 20-18 to approve a bill to expand Medicaid, the health program for the… »   

Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in newly… »   

Bayer’s acne pill Diane 35 and its generic versions are safe to use in certain women when other options have… »